Curaleaf Disputes Aurora's Rejection of Sweetened Takeover Offer
Curaleaf disputes Aurora Cannabis's rejection of its enhanced takeover bid, claiming a 217% premium when cash is excluded. Aurora's board de...
Closed · back Mon 8am PT
Call (650) 955-1836Today: 8am–5pm PT · Mon–Fri 8am–5pm PT
We'll call you back when we open, Mon from 8am PT.
Curaleaf disputes Aurora Cannabis's rejection of its enhanced takeover bid, claiming a 217% premium when cash is excluded. Aurora's board de...
Aurora Cannabis rejected Curaleaf's revised takeover bid, saying it undervalues the company. The Canadian LP's board signaled openness to ot...
Aurora Cannabis completed a multimillion-dollar expansion of its German EU-GMP facility, more than doubling annual flower production capacit...
Curaleaf has filed an updated offering circular with regulators, incorporating its increased acquisition bid for Canadian cannabis producer ...
Curaleaf has raised its hostile takeover offer for Aurora Cannabis to $5 per share, valuing the struggling Canadian LP at roughly $1.2 billi...
Business
Aurora Cannabis urged shareholders to reject Curaleaf's hostile takeover bid, citing its debt-free balance sheet and $149M cash position as ...
Business
Aurora Cannabis is urging shareholders to reject Curaleaf's $272 million hostile takeover bid, saying the U.S. operator made inaccurate clai...
Business
Curaleaf Holdings bypassed Aurora Cannabis leadership to launch a hostile takeover bid, filing a tender offer directly with shareholders on ...
Business
Curaleaf Holdings launched a hostile takeover bid for Aurora Cannabis valued at $2.3 billion, offering cash and stock at a 30% premium. The ...